Itamar Medical Ltd. (ITMR)
Stock Price:
$21.20 USD
1.28 (6.43%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
298.99M |
| Revenue (ttm) |
33.58M |
| Net Income (ttm) |
-5.27M |
| Shares Out |
14.10M |
| EPS (ttm) |
-0.72 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 2, 2020 |
| Last Price |
$21.20 |
| Previous Close |
$19.92 |
| Change ($) |
1.28 |
| Change (%) |
6.43% |
| Day's Open |
20.90 |
| Day's Range |
20.39 - 21.34 |
| Day's Volume |
32,659 |
| 52-Week Range |
7.66 - 23.09 |
More Stats
| Market Cap |
298.99M |
| Enterprise Value |
291.48M |
| Earnings Date (est) |
Aug 12, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
14.10M |
| Float |
9.37M |
| EPS (basic) |
-0.02 |
| EPS (diluted) |
-0.72 |
| FCF / Share |
-0.02 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
257,555 |
| Short Ratio |
19.75 |
| Short % of Float |
n/a |
| Beta |
0.51 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
8.90 |
| PB Ratio |
5.98 |
| Revenue |
33.58M |
| Operating Income |
-4.89M |
| Net Income |
-5.27M |
| Free Cash Flow |
-4.78M |
| Net Cash |
7.52M |
| Net Cash / Share |
0.53 |
| Gross Margin |
72.29% |
| Operating Margin |
-14.57% |
| Profit Margin |
-16.90% |
| FCF Margin |
-14.23% |
| ROA |
-6.87% |
| ROE |
-17.11% |
| ROIC |
-42.10% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (6)
| Buy |
6 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$24.00*
(13.21% upside)
Low
21.0
Current: 21.20
High
30.0
Target: 24.00
*Average 12-month price target from 6 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|
| Revenue | 31.26 | 24.19 | 20.70 | 18.44 | 16.81 |
| Revenue Growth | 29.22% | 16.85% | 12.26% | 9.72% | - |
| Gross Profit | 24.27 | 18.46 | 15.70 | 13.46 | 12.41 |
| Operating Income | -4.89 | -3.12 | -5.85 | -10.01 | -5.46 |
| Net Income | -5.27 | -1.73 | -5.30 | -14.40 | -2.25 |
| Shares Outstanding | 288 | 288 | 288 | 288 | 288 |
| Earnings Per Share | -0.02 | -0.01 | -0.02 | -0.05 | -0.02 |
| Operating Cash Flow | -4.23 | -3.88 | -6.18 | -10.63 | -8.61 |
| Capital Expenditures | -0.55 | -0.31 | -0.30 | -0.46 | -0.56 |
| Free Cash Flow | -4.78 | -4.19 | -6.48 | -11.09 | -9.17 |
| Cash & Equivalents | 15.12 | 6.47 | 10.82 | 26.14 | 0.00 |
| Total Debt | 7.60 | 5.44 | 13.57 | 24.59 | - |
| Net Cash / Debt | 7.52 | 1.03 | -2.76 | 1.55 | 0.00 |
| Assets | 33.21 | 18.39 | 21.28 | 35.55 | - |
| Liabilities | 16.54 | 11.70 | 19.90 | 30.31 | - |
| Book Value | 16.66 | 6.69 | 1.38 | 5.24 | - |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Itamar Medical Ltd. |
| Country |
Israel |
| Employees |
184 |
| CEO |
Gilad Glick |
Stock Information
| Ticker Symbol |
ITMR |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: ITMR |
Description
Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.